Pinnacle Associates’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $3.45M | Buy |
|
|||||
|
2025
Q2 | $4.15M | Sell |
|
|||||
|
2025
Q1 | $5.19M | Sell |
|
|||||
|
2024
Q4 | $6.25M | Buy |
|
|||||
|
2024
Q3 | $5.71M | Sell |
|
|||||
|
2024
Q2 | $6.62M | Buy |
|
|||||
|
2024
Q1 | $5.57M | Buy |
|
|||||
|
2023
Q4 | $5.71M | Buy |
|
|||||
|
2023
Q3 | $4.26M | Sell |
|
|||||
|
2023
Q2 | $5.68M | Sell |
|
|||||
|
2023
Q1 | $5.07M | Sell |
|
|||||
|
2022
Q4 | $5.95M | Sell |
|
|||||
|
2022
Q3 | $5.4M | Sell |
|
|||||
|
2022
Q2 | $8M | Sell |
|
|||||
|
2022
Q1 | $9.9M | Sell |
|
|||||
|
2021
Q4 | $11.9M | Sell |
|
|||||
|
2021
Q3 | $12.8M | Sell |
|
|||||
|
2021
Q2 | $14M | Buy |
|
|||||
|
2021
Q1 | $16.5M | Sell |
|
|||||
|
2020
Q4 | $21.9M | Sell |
|
|||||
|
2020
Q3 | $13.8M | Sell |
|
|||||
|
2020
Q2 | $13.6M | Sell |
|
|||||
|
2020
Q1 | $7.94M | Sell |
|
|||||
|
2019
Q4 | $9.07M | Buy |
|
|||||
|
2019
Q3 | $3.12M | Buy |
|